Repurposed Genentech drug fails in Italian study against Covid
June 18, 2020 at 16:26 PM EDT
The company is continuing three of its own studies of its rheumatoid arthritis drug, including one combining it with Gilead's remdesivir.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|